Total Funding
58
88
Total FundingSeries B raised
Growth Score
-3 pts
Heat Score
27 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
632
Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.
- Past Role: Turning Point Therapeutics, President and Chief Executive Officer
- Paolo Tombesi: CFO & Executive VPPast Role: Epizyme, Chief Financial Officer
About the Company
Avenzo Therapeutics' objective is to improve the lives of cancer patients by providing medicines that improve on the current standard of care.
Women Founded
